|
|
THIRD ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS
AND BEST PRACTICES
FORUM
|
ATTEND ONSITE
September 10 - 12, 2013
PARKROYAL Kuala Lumpur Hotel
Kuala Lumpur, Malaysia
|
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months
|
|
FEATURING IFPMA CODE WORKSHOP
|
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (www.ifpma.org) is offering an IFPMA Code Workshop on Monday, September 9 , 2013.
Registration information coming soon.
|
|
KEYNOTE SPEAKERS
|
Ian Bell
President, Allergan Asia Pacific, Singapore |
Dr. Jean-François Manzoni, MBA, PhD
Shell Chaired Professor of Human Resources and Organisational Development, Director, INSEAD Global Leadership Centre (IGLC), Professor of Management Practice, INSEAD, Singapore
|
Prof. Dr. Agus Purwadianto, MD, JD, PhD
Senior Staff on Legal & Human Rights Affairs, Coordinating Ministry for People's Welfare, Indonesia, Expert Staff for Medico-Legal, Minister of Health, Government of Indonesia, Member, Commission for Bioethics, Member, Medical Ethics Board, Indonesian Doctors Association, Jakarta, Indonesia |
Russell Williams
President, Rx&D Canada, Chair, IFPMA Code Compliance Network, Former Member, National Assembly of Quebec, Ottawa, Canada
|
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Masood Ahmed
Vice President, Regional Compliance Officer- Asia Pacific, sanofi-aventis group, Singapore |
John Auerbach, MA
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China
|
Wayne Baker
Senior Vice President and Chief Sales Officer, Advanced Health Media LLC, Bridgewater, NJ, USA |
Jeff Berry
Regional Director, Ethics and Compliance, Asia Pacific & Japan, Abbott, Singapore |
Maija Burtmanis, Esq.
Associate General Counsel, Alcon Asia, Singapore
|
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA |
Eugene Chen, Esq.
Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China |
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
|
Alan Chin
Ethics & Compliance Officer, Malaysia & Singapore, Eli Lilly, Co-Chair, Marketing Practices Committee, Singapore Association of Pharmaceutical Industries (SAPI), Singapore |
Peter Claude
Partner, PricewaterhouseCoopers, San Francisco, CA, USA |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Buckinghamshire, UK
|
Karen Eryou
Director and Head, Quality and Compliance, UCB Pharma - Greater China and SE Asia, Shanghai, China |
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd., Singapore |
Andrew Frye, MBA
Vice President, DKSH Healthcare, Former Commercial Director, Pharma, Abbott Laboratories, Bangkok, Thailand
|
Jan Oliver Huber, Doktor der Rechte
General Secretary, Pharmig - Verband der, Pharmazeutischen Industrie Õsterreichs, Member, IFPMA Code Compliance Network, Vienna, Austria |
Joanna Gao
Area Compliance Officer, China/HK, GlaxoSmithKline Pte Ltd., Beijing, China |
Jeffrey Hessekiel, Esq.
Partner, Arnold & Porter, Former Chief Compliance & Quality Officer, Gilead Sciences, Inc., San Francisco, CA, USA
|
Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers Consultants (Shenzhen) Limited, Shanghai, China |
Yota Kikuchi
Manager, Promotion Code & Public Affairs, sanofi-aventis, Vice Chairman, Code Practices Committee, Japan Pharmaceutical Manufacturers Association (JPMA), Member, IFPMA Code Compliance Network, Tokyo, Japan |
Liz MacGillivray
Compliance Director, Corporate Integrity and Compliance, Novartis International AG, Basel, Switzerland
|
Deborah Monk
Director, Innovation and Industry Policy, Medicines Australia, Manager, Medicines Australia's Code of Conduct, Deakin, Australian Capital Territory, Australia |
Tamara Music
Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland |
Kirk Ogrosky, Esq.
Partner, Arnold & Porter, Former Head of Healthcare Fraud Enforcement, Criminal Division, US Department of Justice, Washington, DC, USA
|
Gonca Sönmez, Esq.
Compliance Counsel, Novo Nordisk Region International Operations, Zürich, Switzerland |
Heather Simmonds
Director and Chair, Code of Practice Panel, Prescription Medicines Code of Practice Authority, Vice-Chair, IFPMA Code Compliance Network, London, UK |
Sabina Sudan
Vice President, Compliance Officer - Emerging Markets Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore
|
Trudy Tan
Regional Compliance Director, AstraZeneca, Shanghai, China |
Rhys Tee
Associate Director, Compliance (APAC), Biogen Idec (Singapore) Pte Ltd, Singapore |
Francisco P. Tranquilino, MD, FPCP
Technical Consultant, Ethics Committee, Pharmaceutical and Healthcare Association of the Philippines (PHAP), Special Assistant to the Dean and College Secretary, University of the Philippines College of Medicine, Manila, Philippines
|
|
THIRD ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
September 10 - 12, 2013
|
ATTEND ONSITE
PARKROYAL Kuala Lumpur Hotel
Kuala Lumpur, Malaysia
|
OR |
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months
|
 |
|
|
|
SAVE THE DATES
|
|
SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals
Cosponsored by Pharmaceutical Compliance Forum
May 21 - 23, 2013
Meliá Castilla Hotel
Madrid, Spain
www.InternationalPharmaCongress.com
|
|
THIRD ASIA PACIFIC
PHARMACEUTICAL COMPLIANCE
CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by Pharmaceutical Compliance Forum
September 10 - 12, 2013
PARKROYAL Kuala Lumpur Hotel
Kuala Lumpur, Malaysia
www.AsianPharmaCongress.com
|
|
FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 28 - 30, 2013
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com
|
|
|
2013 ASIA PACIFIC PHARMA CONGRESS PLANNING COMMITTEE
|
Gareth Lee, Esq.
Associate General Counsel & Head of Compliance, Asia Pacific, Allergan Inc., Singapore (Co chair)
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore (Co chair)
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Domme (Asia Ltd.), Manila, Philippines (Co chair)
Tom M. Zerull
Regional Compliance Director, AAAME & Japan, AbbVie, Former Regional Director, Asia Pacific, Office of Ethics & Compliance, Abbott, Singapore (Co chair)
Masood Ahmed
Vice President, Regional Compliance Officer- Asia Pacific, sanofi-aventis group, Singapore
John Auerbach, MA
Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China
Wayne Baker
Senior Vice President and Chief Sales Officer, Advanced Health Media LLC, Bridgewater, NJ, USA
Scott Bass, Esq.
Partner and Chair, Global Life Sciences Team, Sidley Austin LLP, Washington, DC, USA
Jeff Berry
Regional Director, Ethics and Compliance, Asia Pacific & Japan, Abbott, Singapore
Maija Burtmanis, Esq.
Associate General Counsel, Alcon Asia, Singapore
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA
Eugene Chen, Esq.
Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China
Bernice Cheng, Esq.
Executive Counsel, Transactions Compliance, Asia Pacific, GE Corporate, Shanghai, China
Peter Chua
Compliance Director, Asia Pacific, Covidien, Singapore
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Buckinghamshire, UK
|
Marc Eigner, MS, MBA
Partner, Polaris, New York, NY, USA
Karen Eryou
Director and Head, Quality and Compliance, UCB Pharma - Greater China and SE Asia, Shanghai, China
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd., Singapore
Erinn Hutchinson
Partner, Global Pharmaceuticals and Life Sciences, PwC, Shanghai, China
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA
Howard Lin
Regional Asia Operations Ethics and Compliance Officer, Lilly, Hong Kong
Liz MacGillivray
Compliance Director, Corporate Integrity and Compliance, Novartis International AG, Basel, Switzerland
Tamara Music
Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland
Michael O'Connor, MS
Executive Director, IS Business Consulting, Boehringer Ingelheim, New York, NY, USA
John Patrick Oroho, Esq. (Suggested)
Executive Vice President and Chief Strategy Office, Porzio Life Sciences, LLC, Morristown, NJ, USA
Dusan Rehak, Esq.
Regional Compliance Director - Asia, Pfizer, Kuala Lumpur, Malaysia
Gonca Sönmez, Esq.
Compliance Counsel, Novo Nordisk Region International Operations, Zürich, Switzerland
Sabina Sudan
Vice President, Compliance Officer - Emerging Markets Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore
Trudy Tan
Regional Compliance Director, AstraZeneca, Shanghai, China
Rhys Tee
Associate Director, Compliance (APAC), Biogen Idec (Singapore) Pte Ltd, Singapore
Peerapan Tungsuwan, LLM
Partner and Chair, Asia Pacific Life Sciences Group, Baker & McKenzie, Bangkok, Thailand
Douglas Worthington, Esq.
Head of Compliance & Ethics, Asia Pacific, Bristol-Myers Squibb, New York, NY, USA
|
|
Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan
|
|
|
|
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the Asia Pacific Pharma Congress May Be Submitted Through Our Online Form.
- Click Here -
|
|
|
|
SPONSORED BY:
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
COSPONSORED BY:
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
|
|
|
CO CHAIRS
|
Gareth Lee, Esq.
Associate General Counsel & Head of Compliance, Asia Pacific, Allergan Inc., Singapore
|
Abdul Luheshi, MBA, PhD
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore
|
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Domme (Asia Ltd.), Manila, Philippines
|
Tom M. Zerull, CPA
Regional Compliance Director, Asia, Australia, Africa, Middle East & Japan, AbbVie, Former Regional Director, Asia Pacific, Office of Ethics & Compliance, Abbott, Singapore
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
BRONZE
|
|
|
MEDIA PARTNER
|
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
2011 - Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
2013 - Madrid, Spain
2013 - Kuala Lumpur, Malaysia
|
|
|
FOLLOW ASIA PACIFIC PHARMA CONGRESS ON
|
|
|
|
|
|
|
|
